Clinical and epidemiological evidence indicate a relationship between thyroid diseases and melanoma. In particular, the hypothyroidism condition appears to promote melanoma spread, which suggests a protective role of thyroid hormones against disease progression. In addition, experimental data suggest that, in addition to thyroid hormones, other hormonal players of the hypothalamic-pituitary-thyroid (HPT) axis, namely the thyrotropin releasing hormone and the thyrotropin, are likely to affect melanoma cells behavior. This information warrants further clinical and experimental studies in order to build a precise pattern of action of the HPT hormones on melanoma cells. An improved knowledge of the involved molecular mechanism(s) could lead to a better and possibly personalized clinical management of these patients.

Is Melanoma Progression Affected by Thyroid Diseases? / Ulisse, Salvatore; Baldini, Enke; Pironi, Daniele; Gagliardi, Federica; Tripodi, Domenico; Lauro, Augusto; Carbotta, Sabino; Tarroni, Danilo; D'Armiento, Matteo; Morrone, Aldo; Forte, Flavio; Frattaroli, Flaminia; Persechino, Severino; Odorisio, Teresa; D'Andrea, Vito; Lori, Eleonora; Sorrenti, Salvatore. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 23:17(2022). [10.3390/ijms231710036]

Is Melanoma Progression Affected by Thyroid Diseases?

Ulisse, Salvatore
;
Baldini, Enke;Pironi, Daniele;Gagliardi, Federica;Tripodi, Domenico;Lauro, Augusto;Carbotta, Sabino;Tarroni, Danilo;Morrone, Aldo;Frattaroli, Flaminia;Persechino, Severino;D'Andrea, Vito;Lori, Eleonora;Sorrenti, Salvatore
2022

Abstract

Clinical and epidemiological evidence indicate a relationship between thyroid diseases and melanoma. In particular, the hypothyroidism condition appears to promote melanoma spread, which suggests a protective role of thyroid hormones against disease progression. In addition, experimental data suggest that, in addition to thyroid hormones, other hormonal players of the hypothalamic-pituitary-thyroid (HPT) axis, namely the thyrotropin releasing hormone and the thyrotropin, are likely to affect melanoma cells behavior. This information warrants further clinical and experimental studies in order to build a precise pattern of action of the HPT hormones on melanoma cells. An improved knowledge of the involved molecular mechanism(s) could lead to a better and possibly personalized clinical management of these patients.
2022
BRAF mutations; cancer; estrogen; melanoma; papillary thyroid cancer; thyroid diseases; thyroid hormone; humans; hypothalamo-hypophyseal system; thyroid hormones; thyrotropin; melanoma; thyroid diseases
01 Pubblicazione su rivista::01a Articolo in rivista
Is Melanoma Progression Affected by Thyroid Diseases? / Ulisse, Salvatore; Baldini, Enke; Pironi, Daniele; Gagliardi, Federica; Tripodi, Domenico; Lauro, Augusto; Carbotta, Sabino; Tarroni, Danilo; D'Armiento, Matteo; Morrone, Aldo; Forte, Flavio; Frattaroli, Flaminia; Persechino, Severino; Odorisio, Teresa; D'Andrea, Vito; Lori, Eleonora; Sorrenti, Salvatore. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 23:17(2022). [10.3390/ijms231710036]
File allegati a questo prodotto
File Dimensione Formato  
Ulisse_Is-Melanoma-Progression_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 562.84 kB
Formato Adobe PDF
562.84 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1656154
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact